Hinge Health is trading 4.14% down at $89.01 after no clear company-specific catalyst emerged in available August 28, 2026 coverage.
- Recent company news remains focused on strong second-quarter results and the planned $105 million Cylinder Health acquisition, both announced August 4.
- Broad markets are slightly lower, but the modest decline does not clearly explain the sharper stock-specific move.